Clinical Efficacy and Safety of Monthly Oral Ibandronate 100 Mg Versus Monthly Intravenous Ibandronate 1 Mg in Japanese Patients With Primary Osteoporosis
Osteoporosis International - United Kingdom
doi 10.1007/s00198-015-3175-1
Full Text
Open PDFAbstract
Available in full text
Date
May 23, 2015
Authors
Publisher
Springer Science and Business Media LLC